Copy to clipboard 
As growth in orthopedic surgery demand continues to rapidly outpace surgeon capacity, one technology company’s innovative, AI-enabled software platform is helping streamline the end-to-end surgical process. Enhatch, provider of the leading cloud-based Intelligent Surgery platform, announced today that it has raised a significant growth investment led by software growth equity firms Trousdale Capital, and Apis Holdings, with participation by Enhatch’s existing major investors. Enhatch’s Intelligent Surgery platform provides leading medical device manufacturers access to powerful tools previously out of reach. These technologies will benefit orthopedic and spine device manufacturers, surgeons, and patients by making surgeries faster, safer, and smarter.
“A key objective with this funding is to integrate Intelligent Surgery into every aspect of the medical device industry and to ensure our partners have an enterprise-level customer experience,” says Peter Verrillo, CEO of Enhatch. “We are committed to providing a robust, end-to-end solution that allows surgeons to work more efficiently, procedures to become more accurate, and companies to remain competitive no matter their size or balance sheet. We are delivering artificial intelligence to level the playing field; allowing any startup, small or midsize device company to leverage an enterprise platform more powerful than the largest device companies in the world.”
“The future of surgery is through artificial intelligence,” says Verrillo. “Before the pandemic, surgeons were already experiencing significant burnout due to rapidly increasing volume of surgeries paired with process inefficiencies. As surgeries are rapidly returning, the problem of surgeon burnout and capacity are becoming critical. We eliminate these process inefficiencies to build a better experience for the surgeon and patient, while reducing costs for the device manufacturer.”
“Recent breakthroughs in artificial intelligence, surgical robotics, and 3D printing are revolutionizing surgeries in the same way advents such as laparoscopy transformed surgeries in the 20th century”, says Nima Shahian, founder and managing partner of Trousdale Capital, and recently appointed member of Enhatch’s board of directors. “We’re excited to partner with Enhatch in disrupting the surgical supply chain to deliver cost savings, surgical optimization, and enterprise efficiency to medical device companies, surgeons, and patients.”
AI will make a significant impact in surgery in the coming years, as the industry requires a more streamlined workflow. In the coming months, Enhatch will announce several key product enhancements that will accelerate the automation and adoption of patient specific technologies.
Since the investment, Enhatch staff has doubled in size. One-third of employees are located in Tulsa, Okla. holding positions in dev ops, sales, marketing, and customer success.
“In partnership with the broader community, we continue to make significant investments in talent and quality of life here in Tulsa,” says Jay Calhoun, managing partner of Apis Holdings and chairman of Enhatch’s board of directors. “We think these strategic investments directly benefit technology, data, and service companies like Enhatch, who are seeking long-term partners who can help grow their operations to enterprise scale. We’ve been able to respond quickly to Enhatch’s aggressive hiring needs, pulling together a powerful combination of top-notch talent and friendly, customer-oriented team members. We do this while collaborating with management to build an enduring company with strong unit economics.”
In March, Crunchbase named Tulsa as the “next stop for the great tech migration.” Tulsa is becoming a home for tech startups and scale-oriented technology companies due to its low cost of living, high quality of life, and strong community.
Source: Enhatch
As growth in orthopedic surgery demand continues to rapidly outpace surgeon capacity, one technology company’s innovative, AI-enabled software platform is helping streamline the end-to-end surgical process. Enhatch, provider of the leading cloud-based Intelligent Surgery platform, announced today that it has raised a significant growth investment...
As growth in orthopedic surgery demand continues to rapidly outpace surgeon capacity, one technology company’s innovative, AI-enabled software platform is helping streamline the end-to-end surgical process. Enhatch, provider of the leading cloud-based Intelligent Surgery platform, announced today that it has raised a significant growth investment led by software growth equity firms Trousdale Capital, and Apis Holdings, with participation by Enhatch’s existing major investors. Enhatch’s Intelligent Surgery platform provides leading medical device manufacturers access to powerful tools previously out of reach. These technologies will benefit orthopedic and spine device manufacturers, surgeons, and patients by making surgeries faster, safer, and smarter.
“A key objective with this funding is to integrate Intelligent Surgery into every aspect of the medical device industry and to ensure our partners have an enterprise-level customer experience,” says Peter Verrillo, CEO of Enhatch. “We are committed to providing a robust, end-to-end solution that allows surgeons to work more efficiently, procedures to become more accurate, and companies to remain competitive no matter their size or balance sheet. We are delivering artificial intelligence to level the playing field; allowing any startup, small or midsize device company to leverage an enterprise platform more powerful than the largest device companies in the world.”
“The future of surgery is through artificial intelligence,” says Verrillo. “Before the pandemic, surgeons were already experiencing significant burnout due to rapidly increasing volume of surgeries paired with process inefficiencies. As surgeries are rapidly returning, the problem of surgeon burnout and capacity are becoming critical. We eliminate these process inefficiencies to build a better experience for the surgeon and patient, while reducing costs for the device manufacturer.”
“Recent breakthroughs in artificial intelligence, surgical robotics, and 3D printing are revolutionizing surgeries in the same way advents such as laparoscopy transformed surgeries in the 20th century”, says Nima Shahian, founder and managing partner of Trousdale Capital, and recently appointed member of Enhatch’s board of directors. “We’re excited to partner with Enhatch in disrupting the surgical supply chain to deliver cost savings, surgical optimization, and enterprise efficiency to medical device companies, surgeons, and patients.”
AI will make a significant impact in surgery in the coming years, as the industry requires a more streamlined workflow. In the coming months, Enhatch will announce several key product enhancements that will accelerate the automation and adoption of patient specific technologies.
Since the investment, Enhatch staff has doubled in size. One-third of employees are located in Tulsa, Okla. holding positions in dev ops, sales, marketing, and customer success.
“In partnership with the broader community, we continue to make significant investments in talent and quality of life here in Tulsa,” says Jay Calhoun, managing partner of Apis Holdings and chairman of Enhatch’s board of directors. “We think these strategic investments directly benefit technology, data, and service companies like Enhatch, who are seeking long-term partners who can help grow their operations to enterprise scale. We’ve been able to respond quickly to Enhatch’s aggressive hiring needs, pulling together a powerful combination of top-notch talent and friendly, customer-oriented team members. We do this while collaborating with management to build an enduring company with strong unit economics.”
In March, Crunchbase named Tulsa as the “next stop for the great tech migration.” Tulsa is becoming a home for tech startups and scale-oriented technology companies due to its low cost of living, high quality of life, and strong community.
Source: Enhatch
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.
